Tower Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017

◆英語タイトル:Tower Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017
◆商品コード:DATA904C3276
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:グローバル
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Tower Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
Summary

Tower Resources Ltd (Tower Resources), formerly Tower Energy Ltd is a junior mineral exploration company. The company operates in the business of mining, discovering and developing of economic mineral projects. It explores for gold, silver and copper. Tower Resources operates projects such as Rabbit North, Nechako Gold and More Creek projects. The company’s Rabbit North copper and gold project comprises 34 mineral tenures, which covers 16,400 hectares; Nechako Gold property comprises 10 mineral tenures totalling 2,975 hectares in the Nechako Plateau Region of central British Columbia; and More Creek property comprises five mineral tenures totalling 6,430 hectares in the Golden Triangle District of northwest British Columbia. Tower Resources is headquartered in Vancouver, British Columbia, Canada.

Tower Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational metrics, analysis and provides a strategic insight into the company. The report provides an annual and quarterly overview of oil and gas reserves and production, changes in reserves, costs incurred and results of oil and gas operations, acreage and well details, share price performance and key valuation metrics.

Scope

The report provides in-depth analysis and insights into companies’ capital spending, revenues, oil and gas reserves, production, and performance measures. Its scope includes the following –
- The report provides detailed and unique insight information on the key operational metrics. It gives a comprehensive overview of oil and gas production and reserves, costs incurred and results of oil and gas operations, acreage and well details and other performance metrics.
- Provides details with respect to the company’s oil and gas reserves and production information by country. It further consists of in-depth information on the company’s expenditures in relation to the acquisition, exploration and development activities; developed and undeveloped acreage position; key costs and revenue information; and performance metrics of the company as disclosed in its annual reports and regulatory filings.
- Provides a comprehensive overview of the company’s share price performance and key valuation metrics such as market capitalization, enterprise value, EV/Production ($boe/d) and EV/Proved Reserve ($/boe)
- Provides information on key operational and financial metrics on an annual and quarterly basis. The annual information provided is for a five-year period and the quarterly information is for the last five quarters.

*Note:

1. The scope mentioned above is generic and may not apply to all the companies. The report is based on the information disclosed by the companies in their annual and quarterly reports, regulatory filings and other company documents and sources.
2. Quarterly information is provided only for the companies that are December ending and files quarter reports and documents.
3. There can be cases where countries/regions data column/Charts will be blank. This can be due to the fact that the company might have discontinued the reporting of those countries/regions. Information that is not disclosed by the company may not be available in the report.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
- Be up-to-date with the latest information and in-depth analysis of the operational metrics of the company.
- Identify M&A targets from up-to-date information and in-depth analysis on financial and operational metrics of your competitors.
- Rank your performance against other companies in the exploration and production (E&P) sector using operational and financial benchmarking metrics.
- Formulate your strategies based on in-depth analysis of your competitors’ financial and operational data.
- Exploit the strengths and weakness of your closest competitors by comparing and analyzing their financial and operational metrics.
- Establish relative performance among the industry’s players based on key operational and financial measures.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 2
Company Snapshot 3
Key Information 3
Company Overview 3
Tower Resources Ltd, Valuation and Financial Data, 2013-2017 4
Tower Resources Ltd, Share Price Performance, 2013-2017 4
Tower Resources Ltd, E&P Costs Trends 5
Oil and Gas Cost Per boe, US$/boe 8
Recent Developments 9
Tower Resources Ltd – Recent Developments 9
Jul 31, 2018: Tower announces OTCQB listing under the symbol TWRFF 9
May 29, 2018: Tower Resources Announces Corporate Update 9
May 15, 2018: Tower Resources Identifies High Grade Till Samples at Nechako 10
May 02, 2018: Tower Resources Announces Appointment of New Board of Directors 11
Appendix 12
Methodology 12
Coverage 12
Secondary Research 12
Primary Research 13
Data Information Sources 13
Company Source 13
SEC/Other Regulatory Filings 13
Other Sources 13
Expert Panel Validation 13
Data Definition 13
Oil and Gas Reserves 13
Units of Measure 14
About GlobalData 15
Disclosure 15
Disclaimer 15

List of Tables
Table 1: Tower Resources Ltd, Key Facts 3
Table 2: Tower Resources Ltd, Share Price Performance, 2013-2017 4
Table 3: Tower Resources Ltd, Key Valuation Metrics, 2013-2017 4
Table 4: Tower Resources Ltd, Upstream Capital Expenditure, US$ mil, 2013-2017 5
Table 5: Tower Resources Ltd, Proved and Unproved Acquisition Costs, By Country/Region, US$ mil, 2013-2017 6
Table 6: Tower Resources Ltd, Exploration and Development Costs, By Country/Region, US$ mil, 2013-2017 7
Table 7: Tower Resources Ltd, Reserves Replacement, Finding and Development Costs, Finding Cost and Proved Acquisition Costs Per boe, US$/boe, 2013-2017 8

★海外企業調査レポート[Tower Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DPR Construction Inc:企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Protagen AG:企業の製品パイプライン分析2018
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • WH Ireland Group Plc (WHI):企業の財務・戦略的SWOT分析
    WH Ireland Group Plc (WHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Visonic Ltd.:企業の戦略的SWOT分析
    Visonic Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Jinchuan Group International Resources Co. Ltd:企業の戦略・SWOT・財務情報
    Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Response Biomedical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • Mironid Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment of degenerative kidney diseases, chronic inflammatory diseases, and cancer. Its drug discove …
  • China Construction Bank Corp
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Yatra Online, Inc. (YTRA):企業の財務・戦略的SWOT分析
    Yatra Online, Inc. (YTRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Abbott Molecular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Molecular Inc (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical diagnostic company that provides molecular testing solutions. The company’s products include infectious disease products, oncology products, genetics products, automation products, molecular diagnostics …
  • Mmi Holdings Ltd.
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CTS Corp (CTS):企業の財務・戦略的SWOT分析
    Summary CTS Corp (CTS) is a manufacturer of actuators, sensors and electronic components. The company offers products such as controls, pedals, piezoelectric sense products, sensors, switches, transducers, RFI filters, frequency control products, RF filters, specialty capacitors, specialty resistors …
  • Hypera SA:企業の戦略・SWOT・財務情報
    Hypera SA - Strategy, SWOT and Corporate Finance Report Summary Hypera SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • eFFECTOR Therapeutics Inc:企業のM&A・事業提携・投資動向
    eFFECTOR Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's eFFECTOR Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • YGM Trading Ltd.:企業の戦略・SWOT・財務情報
    YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Le Chateau Inc. (CTU):企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wexford Health Sources Inc:企業の戦略的SWOT分析
    Wexford Health Sources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the app …
  • Axela Inc:製品パイプライン分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆